News
03-01-2011, 12:30 AM
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer.
More... (http://www.news-medical.net/news/20110301/Leptin-receptor-antagonist-peptide-demonstrates-efficacy-against-triple-negative-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20110301/Leptin-receptor-antagonist-peptide-demonstrates-efficacy-against-triple-negative-breast-cancer.aspx)